1. 55112-42-0
2. 4-methylpiperazine-1-carbonyl Chloride Hydrochloride
3. 4-methyl-1-piperazinecarbonyl Chloride Hcl
4. 4-methylpiperazine-1-carbonyl Chloride Monohydrochloride
5. 1-piperazinecarbonyl Chloride, 4-methyl-, Monohydrochloride
6. 4-methylpiperazine-1-carbonyl Chloride;hydrochloride
7. N-methylpiperazin-4-carbamoyl Chloride Hydrochloride
8. 4-methyl-1-piperazinecarbonyl Chloride, Hcl
9. 1-chlorocarbonyl-4-methylpiperazine Hydrochloride
10. Einecs 259-482-8
11. 7t2r5als8t
12. 4-methyl-1-piperazinecarbonylchloridehydrochloride
13. Schembl321914
14. Dtxsid80203633
15. Wicnynxykznnsn-uhfffaoysa-n
16. Bcp16973
17. Geo-01914
18. Mfcd01074875
19. Akos015897706
20. Ac-24406
21. Ps-10936
22. Ft-0640293
23. Ft-0658732
24. F16753
25. 4-methylpiperazine Carbonylchloride Hydrochloride
26. En300-1265364
27. 1-chlorocarbonyl-4-methyl Piperazine Hydrochloride
28. 1-chlorocarbonyl-4-methyl-piperazine Hydrochloride
29. 4-chlorocarbonyl-1-methyl-piperazine Hydrochloride
30. A830496
31. N-chlorocarbonyl-n'-methylpiperazine Hydrochloride
32. 4-methyl-l-piperazinecarbonyl Chloride Hydrochloride
33. W-200427
34. 4-methyl-1-piperazine Carbonyl Chloride Hydrochloride
35. 4-methyl-l-piperazine Carbonyl Chloride Hydrochloride
36. 4-methyl-piperazine-1-carbonyl Chloride Hydrochloride
37. 4-methylpiperazin-1-ylcarbonyl Chloride Hydrochloride
38. N-methylpiperazine-4-carbamoyl Chloride Hydrochloride
39. F0001-1447
40. N-methylpiperazin-4-carbamoylchloridehydrochloride
41. 1-piperazinecarbonyl Chloride, 4-methyl-, Hydrochloride (1:1)
| Molecular Weight | 199.08 g/mol |
|---|---|
| Molecular Formula | C6H12Cl2N2O |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 23.6 |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 132 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
BUILDING BLOCK
END USE APIs
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
RELATED INTERMEDIATES
Zeon Pharma is a manufacturer and supplier of APIs & Intermediates.
Zeon Pharma is a manufacturer and supplier of APIs & Intermediates.
Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
